Pressotherapy Systems Market Share

The North America pressotherapy systems market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. Increasing blood circulation problems among the population such as peripheral vascular disease (PVDs) along with the upsurge in medical spending are anticipated to drive the regional market. It was observed that, in the United States, nearly 8.7 million people suffer from peripheral vascular disease, with PVD affecting 15 to 20% of people over the age of 65.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of pressotherapy systems is evaluated at USD 194.31 Million.

The pressotherapy systems market size was valued at USD 187.02 Million in 2023 and is expected to reach USD 307.53 Million by the end of 2036, registering around 3.9% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of tired legs, cellulite, low blood circulation, increase in per capita income along with innovative product development are the major factors driving the growth of the market.

North America is set to hold largest industry share by 2036, led by increasing blood circulation problems among the population such as peripheral vascular disease (PVDs) along with the upsurge in medical spending.

DJO Global Inc., BioMatrix Specialty Pharmacy, Elettronica Pagani Srl, Devon Medical Products Inc., Novasonix Technology Sl., Alyssatech Spain, HEAT Spa Kur Therapy Development Inc, Guangzhou Longest Science & Technology Co., Ltd, Doris Electronic Technology Co., Ltd., Unmanned Aircraft Systems

Pressotherapy Systems Market Share